Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - GENEREX BIOTECHNOLOGY CORP | v347309_8k.htm |
June 6, 2013
Office of the Chief Accountant
Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Dear Sirs:
We have read the statements included under Item 4.01 in the Form 8-K dated June 6, 2013 of Generex Biotechnology Corporation to be filed with the Securities and Exchange Commission and we agree with such statements as they relate to our firm.
Yours truly,
/s/ MSCM LLP
MSCM LLP